Literature DB >> 11526125

Evidence of extrahepatic sites of replication of the hepatitis E virus in a swine model.

T P Williams1, C Kasorndorkbua, P G Halbur, G Haqshenas, D K Guenette, T E Toth, X J Meng.   

Abstract

Hepatitis E virus (HEV) is the major cause of enterically transmitted non-A, non-B hepatitis in many developing countries and is also endemic in many industrialized countries. Due to the lack of an effective cell culture system and a practical animal model, the mechanisms of HEV pathogenesis and replication are poorly understood. Our recent identification of swine HEV from pigs affords us an opportunity to systematically study HEV replication and pathogenesis in a swine model. In an early study, we experimentally infected specific-pathogen-free pigs with two strains of HEV: swine HEV and the US-2 strain of human HEV. Eighteen pigs (group 1) were inoculated intravenously with swine HEV, 19 pigs (group 2) were inoculated with the US-2 strain of human HEV, and 17 pigs (group 3) were used as uninoculated controls. The clinical and pathological findings have been previously reported. In this expanded study, we aim to identify the potential extrahepatic sites of HEV replication using the swine model. Two pigs from each group were necropsied at 3, 7, 14, 20, 27, and 55 days postinoculation (DPI). Thirteen different types of tissues and organs were collected from each necropsied animal. Reverse transcriptase PCR (RT-PCR) was used to detect the presence of positive-strand HEV RNA in each tissue collected during necropsy at different DPI. A negative-strand-specific RT-PCR was standardized and used to detect the replicative, negative strand of HEV RNA from tissues that tested positive for the positive-strand RNA. As expected, positive-strand HEV RNA was detected in almost every type of tissue at some time point during the viremic period between 3 and 27 DPI. Positive-strand HEV RNA was still detectable in some tissues in the absence of serum HEV RNA from both swine HEV- and human HEV-inoculated pigs. However, replicative, negative-strand HEV RNA was detected primarily in the small intestines, lymph nodes, colons, and livers. Our results indicate that HEV replicates in tissues other than the liver. The data from this study may have important implications for HEV pathogenesis, xenotransplantation, and the development of an in vitro cell culture system for HEV.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11526125      PMCID: PMC88293          DOI: 10.1128/JCM.39.9.3040-3046.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  49 in total

1.  A novel virus in swine is closely related to the human hepatitis E virus.

Authors:  X J Meng; R H Purcell; P G Halbur; J R Lehman; D M Webb; T S Tsareva; J S Haynes; B J Thacker; S U Emerson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  A divergent genotype of hepatitis E virus in Chinese patients with acute hepatitis.

Authors:  Y Wang; R Ling; J C Erker; H Zhang; H Li; S Desai; I K Mushahwar; T J Harrison
Journal:  J Gen Virol       Date:  1999-01       Impact factor: 3.891

3.  The ORF3 protein of hepatitis E virus is a phosphoprotein that associates with the cytoskeleton.

Authors:  M Zafrullah; M H Ozdener; S K Panda; S Jameel
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  Identity of a novel swine hepatitis E virus in Taiwan forming a monophyletic group with Taiwan isolates of human hepatitis E virus.

Authors:  S Y Hsieh; X J Meng; Y H Wu; S T Liu; A W Tam; D Y Lin; Y F Liaw
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

5.  Transgenic pigs and virus adaptation.

Authors:  R A Weiss
Journal:  Nature       Date:  1998-01-22       Impact factor: 49.962

6.  Evidence that the genomic RNA of hepatitis E virus is capped.

Authors:  Y Kabrane-Lazizi; X J Meng; R H Purcell; S U Emerson
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

7.  Fulminant hepatic failure in pregnant women: acute fatty liver or acute viral hepatitis?

Authors:  S S Hamid; S M Jafri; H Khan; H Shah; Z Abbas; H Fields
Journal:  J Hepatol       Date:  1996-07       Impact factor: 25.083

8.  Seroepidemiology of water-borne hepatitis in India and evidence for a third enterically-transmitted hepatitis agent.

Authors:  V A Arankalle; M S Chadha; S A Tsarev; S U Emerson; A R Risbud; K Banerjee; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

9.  Detection of hepatitis E virus infections among domestic swine in the Kathmandu Valley of Nepal.

Authors:  E T Clayson; B L Innis; K S Myint; S Narupiti; D W Vaughn; S Giri; P Ranabhat; M P Shrestha
Journal:  Am J Trop Med Hyg       Date:  1995-09       Impact factor: 2.345

10.  Determination of hepatitis E virus seroprevalence by using recombinant fusion proteins and synthetic peptides.

Authors:  D A Paul; M F Knigge; A Ritter; R Gutierrez; T Pilot-Matias; K H Chau; G J Dawson
Journal:  J Infect Dis       Date:  1994-04       Impact factor: 5.226

View more
  78 in total

Review 1.  Acute and Persistent Hepatitis E Virus Genotype 3 and 4 Infection: Clinical Features, Pathogenesis, and Treatment.

Authors:  Nassim Kamar; Sven Pischke
Journal:  Cold Spring Harb Perspect Med       Date:  2019-07-01       Impact factor: 6.915

2.  Comparative pathogenesis in specific-pathogen-free chickens of two strains of avian hepatitis E virus recovered from a chicken with Hepatitis-Splenomegaly syndrome and from a clinically healthy chicken.

Authors:  P Billam; T LeRoith; R S Pudupakam; F W Pierson; R B Duncan; X J Meng
Journal:  Vet Microbiol       Date:  2009-06-11       Impact factor: 3.293

3.  Infection Dynamics of Hepatitis E Virus in Wild-Type and Immunoglobulin Heavy Chain Knockout JH -/- Gnotobiotic Piglets.

Authors:  Danielle M Yugo; C Lynn Heffron; Junghyun Ryu; Kyungjun Uh; Sakthivel Subramaniam; Shannon R Matzinger; Christopher Overend; Dianjun Cao; Scott P Kenney; Harini Sooryanarain; Thomas Cecere; Tanya LeRoith; Lijuan Yuan; Nathaniel Jue; Sherrie Clark-Deener; Kiho Lee; Xiang-Jin Meng
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

4.  Heterogeneity and seroprevalence of a newly identified avian hepatitis e virus from chickens in the United States.

Authors:  F F Huang; G Haqshenas; H L Shivaprasad; D K Guenette; P R Woolcock; C T Larsen; F W Pierson; F Elvinger; T E Toth; X J Meng
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

5.  Seasonal pattern of hepatitis E virus prevalence in swine in two different geographical areas of China.

Authors:  Y H Lu; H Z Qian; A Q Hu; X Qin; Q W Jiang; Y J Zheng
Journal:  Epidemiol Infect       Date:  2013-02-06       Impact factor: 2.451

6.  Development and validation of a negative-strand-specific reverse transcription-PCR assay for detection of a chicken strain of hepatitis E virus: identification of nonliver replication sites.

Authors:  P Billam; F W Pierson; W Li; T LeRoith; R B Duncan; X J Meng
Journal:  J Clin Microbiol       Date:  2008-06-18       Impact factor: 5.948

7.  Experimental infection of rabbits with rabbit and genotypes 1 and 4 hepatitis E viruses.

Authors:  Hongxia Ma; Lin Zheng; Yunbo Liu; Chenyan Zhao; Tim J Harrison; Yuyuan Ma; Shuhua Sun; Jingang Zhang; Youchun Wang
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

Review 8.  Zoonotic hepatitis E: animal reservoirs and emerging risks.

Authors:  Nicole Pavio; Xiang-Jin Meng; Christophe Renou
Journal:  Vet Res       Date:  2010-04-02       Impact factor: 3.683

9.  Hepatitis E virus genotype 1 infection of swine kidney cells in vitro is inhibited at multiple levels.

Authors:  H T Nguyen; P Shukla; U Torian; K Faulk; S U Emerson
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

10.  Experimental infection of Balb/c nude mice with Hepatitis E virus.

Authors:  Fen Huang; Wen Zhang; Ga Gong; Congli Yuan; Yijia Yan; Shixing Yang; Li Cui; Jianguo Zhu; Zhibiao Yang; Xiuguo Hua
Journal:  BMC Infect Dis       Date:  2009-06-13       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.